Anwei Lu

701 total citations
33 papers, 496 citations indexed

About

Anwei Lu is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Anwei Lu has authored 33 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Anwei Lu's work include Endometrial and Cervical Cancer Treatments (8 papers), Organ Transplantation Techniques and Outcomes (8 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Anwei Lu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Organ Transplantation Techniques and Outcomes (8 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Anwei Lu collaborates with scholars based in China, Hong Kong and Madagascar. Anwei Lu's co-authors include Shusen Zheng, Weilin Wang, Yan Shen, Tingbo Liang, Yaomin Chen, Min Zhang, Hongliu Cai, Wei Yu, Tao Lan and Chunlin Chen and has published in prestigious journals such as Frontiers in Microbiology, Human Reproduction and Advanced Science.

In The Last Decade

Anwei Lu

33 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anwei Lu China 12 219 156 115 85 82 33 496
Mari Mandai Japan 8 111 0.5× 136 0.9× 30 0.3× 51 0.6× 54 0.7× 13 294
Kanchan Murhekar India 13 203 0.9× 192 1.2× 81 0.7× 17 0.2× 29 0.4× 33 425
Ze‐Xiao Lin China 11 135 0.6× 66 0.4× 196 1.7× 80 0.9× 126 1.5× 23 693
Hee Sik Sun South Korea 16 359 1.6× 370 2.4× 94 0.8× 202 2.4× 44 0.5× 54 775
Taito Fukushima Japan 13 122 0.6× 164 1.1× 24 0.2× 51 0.6× 28 0.3× 43 386
Abram Bunya Kamiza South Africa 10 137 0.6× 60 0.4× 74 0.6× 55 0.6× 47 0.6× 28 346
Xiaoguang Dou China 16 388 1.8× 377 2.4× 112 1.0× 65 0.8× 35 0.4× 72 638
Xiaohong Zhang China 10 136 0.6× 235 1.5× 82 0.7× 67 0.8× 42 0.5× 40 428
John C. Brady United States 12 123 0.6× 37 0.2× 133 1.2× 75 0.9× 59 0.7× 18 488
Sophie Félix France 11 89 0.4× 27 0.2× 70 0.6× 148 1.7× 20 0.2× 23 403

Countries citing papers authored by Anwei Lu

Since Specialization
Citations

This map shows the geographic impact of Anwei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anwei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anwei Lu more than expected).

Fields of papers citing papers by Anwei Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anwei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anwei Lu. The network helps show where Anwei Lu may publish in the future.

Co-authorship network of co-authors of Anwei Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Anwei Lu. A scholar is included among the top collaborators of Anwei Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anwei Lu. Anwei Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qingjing, Haojie Yu, Weiqiang Huang, et al.. (2025). Exploring current hypervirulent Klebsiella pneumoniae infections: insights into pathogenesis, drug resistance, and vaccine prospects. Frontiers in Microbiology. 16. 1604763–1604763. 1 indexed citations
2.
Lu, Anwei, Shuying Lin, Jiajing Li, et al.. (2025). Harmine inhibits oxidative phosphorylation, thus regulating the polarization of macrophages mediated by extracellular adenosine in endometriosis. Human Reproduction. 40(10). 1893–1908. 1 indexed citations
4.
Zhong, Sheng, Quanwei Guo, Xiaona Chen, et al.. (2024). The inhibition of YTHDF3/m6A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer. International Journal of Biological Sciences. 20(3). 916–936. 17 indexed citations
5.
Wang, Qingjing, et al.. (2024). ECMO for bridging lung transplantation. European journal of medical research. 29(1). 628–628. 1 indexed citations
6.
Chen, Xiaona, Yi Hao, Yong Liu, et al.. (2023). NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer. Advanced Science. 10(32). e2302705–e2302705. 67 indexed citations
7.
Chen, Tao, Jia Li, Anwei Lu, et al.. (2022). The oncological and obstetric results of radical trachelectomy as a fertility-sparing therapy in early-stage cervical cancer patients. BMC Women s Health. 22(1). 424–424. 4 indexed citations
8.
Li, Zhiqiang, Chunlin Chen, Ping Liu, et al.. (2021). Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study. Archives of Gynecology and Obstetrics. 305(2). 449–458. 5 indexed citations
9.
Li, Pengfei, Li Wang, Yang Ying, et al.. (2021). The Effect of Laparoscopic Radical Hysterectomy Surgical Volume on Oncology Outcomes in Early-Stage Cervical Cancer. Frontiers in Surgery. 8. 692163–692163. 1 indexed citations
10.
Li, Pengfei, Ziyu Fang, Weili Li, et al.. (2020). Impact of neoadjuvant chemotherapy on the postoperative pathology of locally advanced cervical squamous cell carcinomas: 1:1 propensity score matching analysis. European Journal of Surgical Oncology. 47(5). 1069–1074. 2 indexed citations
11.
Liu, Ping, Cong Liang, Anwei Lu, et al.. (2020). Risk factors and long-term impact of urologic complications during radical hysterectomy for cervical cancer in China, 2004–2016. Gynecologic Oncology. 158(2). 294–302. 17 indexed citations
12.
Zhang, Weifeng, Chunlin Chen, Ping Liu, et al.. (2019). Staging early cervical cancer in China: data from a multicenter collaborative. International Journal of Gynecological Cancer. 29(5). 869–873. 21 indexed citations
13.
Zhang, Weifeng, Chunlin Chen, Ping Liu, et al.. (2019). <p>Impact of pelvic MRI in routine clinical practice on staging of IB1&ndash;IIA2 cervical cancer</p>. Cancer Management and Research. Volume 11. 3603–3609. 24 indexed citations
14.
Cai, Hongliu, et al.. (2019). Tigecycline-induced coagulopathy: a literature review. International Journal of Clinical Pharmacy. 41(6). 1408–1413. 35 indexed citations
15.
Lan, Tao, et al.. (2018). Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma. Medicine. 97(19). e0741–e0741. 49 indexed citations
16.
Tan, Lichao, Weiwei Jiang, Anwei Lu, Haiying Cai, & Liangliang Kong. (2018). miR-155 Aggravates Liver Ischemia/reperfusion Injury by Suppressing SOCS1 in Mice. Transplantation Proceedings. 50(10). 3831–3839. 23 indexed citations
17.
Yu, Wei, et al.. (2018). Forecast of actin-binding proteins as the oncotarget in osteosarcoma &ndash; a review of mechanism, diagnosis and therapy. OncoTargets and Therapy. Volume 11. 1553–1561. 7 indexed citations
18.
Shi, Shaohua, Anwei Lu, Yan Shen, et al.. (2008). Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chinese Medical Journal. 121(7). 625–630. 27 indexed citations
19.
Zheng, Shusen, Yaomin Chen, Tingbo Liang, et al.. (2006). Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transplantation. 12(2). 253–258. 125 indexed citations
20.
Zheng, Shusen, Jian Wu, Weilin Wang, et al.. (2002). [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].. PubMed. 82(7). 445–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026